Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic
  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Revised - Eyecarrot Principal Partner of SIODEC 2019 Congress

Tickers: XTSX:EYC, PINX:EYCCF
Tags: #Healthcare



Oakville, ON / TheNewswire / March 22 2019 - Eyecarrot Innovations Corp., (Eyecarrot) (TSX-V: EYC | OTCQB: EYCCF) is pleased to announce its Principal Sponsorship of the 6th International SIODEC Congress of Behavioral Optometry and Vision Therapy taking place in Granada, Spain from March 27th to 30th, 2019 within the Granada Congress Center located in the centre of a historic and vibrant city.

"We are pleased to continue our support of SIODEC and its constituents. Optometry in Spain is one of the most unified and energetic markets we have ever seen. The passion for Behavioral Optometry, and the growth of this field in Spain, has not been seen in any market around the world. I believe the ability to improve and expand is the same in Spain as it is in many other markets, and that is through technology that can make the everyday lives Optometry Doctors, Vision Therapists and Patients easier", stated Adam Cegielski, CEO of Eyecarrot.

The SIODEC Congress is a high-profile biennial event within the Optometry community and an important resource for optometrists specialising in Vision Therapy. The education sessions will be simultaneously delivered in Spanish and English, as performed in previous years.

"The Eyecarrot Team looks forward to greeting all those in attendance of this years' Congress" said Head of Eyecarrot's Corporate Development and Operations, Adrian Makuch.

Additionally, the corporation is seeking to file an application with the TSX Venture Exchange ("TSX-V") to amend the terms of certain share purchase warrants of the Company, originally issued on November 24, 2017, March 20 and April 27, 2018. A total of 23,633,400 share purchase warrants were originally issued by the Company pursuant to the closing of the equity offerings.

Eyecarrot is seeking the approval of the TSX Venture Exchange to reduce the exercise price of the Amended Warrants to $0.12 per share or such other price as may be acceptable to the TSX Venture Exchange. The Warrants, as amended, include an accelerated expiry provision such that the exercise period of each of the Warrants will be reduced to 30 days if for any 10 consecutive trading days during the unexpired term of such of the Warrants, the closing price of the Corporation's common shares exceeds the amended exercise price by 25% or more (which would be a trading price of $0.15 per common share or higher), with the 30-day expiry period commencing on the day the Issuer either (i) disseminates a press release or (ii) sends a written notice to the holders of the Warrants, advising of the commencement of the Exercise Period.

About Eyecarrot Innovations Corp.

Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor-led home-based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors.

Adam Cegielski

President | CEO

Terry Uppal

Investor Relations

Email: invest@eyecarrot.com

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information:

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2019 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.